Simulations Plus, Inc. (SLP)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Mar 12, 2025

$27.25

P/E Ratio

67.43

Market Cap

$547.52M

Loading...
Description
Add to research

Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.

Metrics
Add to research

Overview

  • HQDurham, NC
  • SectorTechnology Services
  • IndustryPackaged Software
  • TickerSLP
  • Price$27.25+2.56%

Trading Information

  • Market cap$547.52M
  • Float100.00%
  • Average Daily Volume (1m)158,498
  • Average Daily Volume (3m)216,226
  • EPS$0.41

Company

  • Revenue$74.44M
  • Rev growth (1yr)30.51%
  • Net income$0.21M
  • Gross margin53.99%
  • EBITDA margin14.22%
  • EBITDA$2.69M
  • EV$627.00M
  • EV/Revenue8.42
  • P/E67.43
  • P/S7.42
  • P/B2.96
  • Debt/Equity0.71
Documents
Add to research